Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hey1
|
ENSMUSG00000040289.3 | hairy/enhancer-of-split related with YRPW motif 1 |
Myc
|
ENSMUSG00000022346.8 | myelocytomatosis oncogene |
Mxi1
|
ENSMUSG00000025025.7 | MAX interactor 1, dimerization protein |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_8665750_8665944 | Hey1 | 778 | 0.562147 | -0.87 | 7.9e-18 | Click! |
chr3_8666676_8667227 | Hey1 | 13 | 0.968915 | -0.86 | 3.3e-17 | Click! |
chr3_8667986_8668137 | Hey1 | 805 | 0.544412 | -0.83 | 6.9e-15 | Click! |
chr3_8664814_8665107 | Hey1 | 1665 | 0.291761 | -0.82 | 1.9e-14 | Click! |
chr3_8664467_8664812 | Hey1 | 1986 | 0.252187 | -0.82 | 2.8e-14 | Click! |
chr19_53360830_53360981 | Mxi1 | 9118 | 0.128855 | -0.71 | 9.7e-10 | Click! |
chr19_53360654_53360805 | Mxi1 | 9294 | 0.128588 | -0.68 | 1.1e-08 | Click! |
chr19_53359764_53359965 | Mxi1 | 10159 | 0.127389 | -0.60 | 1.3e-06 | Click! |
chr19_53359299_53359450 | Mxi1 | 10649 | 0.126772 | -0.52 | 5.2e-05 | Click! |
chr19_53360248_53360544 | Mxi1 | 9627 | 0.128107 | -0.52 | 5.3e-05 | Click! |
chr15_61986655_61986879 | Myc | 267 | 0.922521 | -0.72 | 5.2e-10 | Click! |
chr15_61986890_61987815 | Myc | 70 | 0.976265 | -0.67 | 2.1e-08 | Click! |
chr15_61987853_61988103 | Myc | 556 | 0.786662 | -0.48 | 2.4e-04 | Click! |
chr15_61991029_61991180 | Myc | 3682 | 0.257658 | 0.40 | 2.6e-03 | Click! |
chr15_61991190_61991341 | Myc | 3843 | 0.253783 | 0.38 | 4.2e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_172294601_172294765 | 17.07 |
Gm14275 |
predicted gene 14275 |
6550 |
0.16 |
chr17_34898151_34899707 | 16.59 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr10_80576603_80578409 | 16.42 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr5_23850355_23851323 | 13.11 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr11_12026145_12026637 | 12.43 |
Grb10 |
growth factor receptor bound protein 10 |
67 |
0.98 |
chr7_44985781_44987176 | 12.04 |
Prmt1 |
protein arginine N-methyltransferase 1 |
14 |
0.83 |
chr11_11684707_11686418 | 11.64 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr3_51340298_51341882 | 11.30 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr15_80760942_80761256 | 11.14 |
Tnrc6b |
trinucleotide repeat containing 6b |
37543 |
0.13 |
chr15_78413496_78413686 | 10.92 |
Mpst |
mercaptopyruvate sulfurtransferase |
3609 |
0.11 |
chr14_115040506_115042372 | 10.68 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr3_60819645_60819924 | 10.54 |
Gm38326 |
predicted gene, 38326 |
31423 |
0.15 |
chr3_87905763_87907208 | 10.33 |
Hdgf |
heparin binding growth factor |
164 |
0.9 |
chr2_132695365_132695663 | 10.25 |
Shld1 |
shieldin complex subunit 1 |
2605 |
0.16 |
chr11_100938783_100940230 | 10.03 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr5_22344110_22345571 | 9.47 |
Reln |
reelin |
138 |
0.95 |
chr4_150132722_150132921 | 9.38 |
Slc2a5 |
solute carrier family 2 (facilitated glucose transporter), member 5 |
3875 |
0.14 |
chr6_88731525_88731683 | 9.22 |
Gm26588 |
predicted gene, 26588 |
5744 |
0.13 |
chr4_133910328_133911371 | 9.12 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
23052 |
0.11 |
chr11_109557350_109557676 | 8.92 |
Arsg |
arylsulfatase G |
13759 |
0.16 |
chr6_52225788_52226610 | 8.53 |
Hoxa9 |
homeobox A9 |
10 |
0.91 |
chr15_79690079_79691459 | 8.48 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr10_127062800_127064205 | 8.23 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr11_117780269_117780842 | 8.22 |
Tmc6 |
transmembrane channel-like gene family 6 |
66 |
0.93 |
chr6_148944404_148945444 | 8.19 |
3010003L21Rik |
RIKEN cDNA 3010003L21 gene |
57 |
0.54 |
chr5_112001700_112002600 | 7.93 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr8_70330272_70331426 | 7.74 |
Gdf1 |
growth differentiation factor 1 |
1032 |
0.34 |
chr4_137795768_137796555 | 7.74 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
69 |
0.98 |
chr19_32222134_32222417 | 7.72 |
Sgms1 |
sphingomyelin synthase 1 |
11262 |
0.22 |
chr7_142568972_142569582 | 7.65 |
H19 |
H19, imprinted maternally expressed transcript |
7261 |
0.1 |
chr11_87755415_87755594 | 7.58 |
Mir142hg |
Mir142 host gene (non-protein coding) |
73 |
0.91 |
chr8_90907824_90909226 | 7.56 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr2_132846257_132847404 | 7.36 |
Crls1 |
cardiolipin synthase 1 |
142 |
0.79 |
chr8_70609185_70610414 | 7.32 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr16_30063252_30064537 | 7.27 |
Hes1 |
hes family bHLH transcription factor 1 |
490 |
0.76 |
chr17_84154262_84154638 | 7.16 |
Gm19696 |
predicted gene, 19696 |
1976 |
0.29 |
chr11_105589210_105590456 | 7.15 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
153 |
0.96 |
chr17_5798459_5798854 | 7.13 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
1 |
0.97 |
chr8_77044918_77045251 | 7.07 |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
82929 |
0.09 |
chr5_129974852_129975023 | 7.05 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
2057 |
0.19 |
chr5_143731658_143732384 | 7.04 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr4_116720426_116721428 | 6.95 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr15_80004559_80005217 | 6.92 |
Mir7213 |
microRNA 7213 |
5862 |
0.12 |
chr5_118480054_118480344 | 6.86 |
Gm15754 |
predicted gene 15754 |
6768 |
0.21 |
chr4_128654325_128654785 | 6.85 |
Phc2 |
polyhomeotic 2 |
147 |
0.95 |
chr17_71268038_71268559 | 6.77 |
Emilin2 |
elastin microfibril interfacer 2 |
299 |
0.88 |
chr14_66265914_66266084 | 6.76 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
14983 |
0.17 |
chr7_35118789_35119702 | 6.76 |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
48 |
0.82 |
chr9_106367425_106368835 | 6.72 |
Dusp7 |
dual specificity phosphatase 7 |
502 |
0.7 |
chr1_86527639_86529135 | 6.70 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr9_61370339_61371660 | 6.63 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr5_137786077_137787112 | 6.62 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr11_120304745_120305917 | 6.61 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
15538 |
0.09 |
chr18_42510920_42511513 | 6.50 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr18_61960597_61960886 | 6.49 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
7657 |
0.21 |
chr4_101674751_101675082 | 6.47 |
Leprot |
leptin receptor overlapping transcript |
27123 |
0.18 |
chr7_123462053_123462460 | 6.36 |
Aqp8 |
aquaporin 8 |
35 |
0.98 |
chr17_87276537_87277114 | 6.34 |
4833418N02Rik |
RIKEN cDNA 4833418N02 gene |
4868 |
0.16 |
chr12_101028530_101029714 | 6.33 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr2_168154178_168154991 | 6.28 |
E130018N17Rik |
RIKEN cDNA E130018N17 gene |
71 |
0.93 |
chr11_31824301_31824782 | 6.20 |
D630024D03Rik |
RIKEN cDNA D630024D03 gene |
17 |
0.98 |
chr9_114563523_114564264 | 6.14 |
Trim71 |
tripartite motif-containing 71 |
476 |
0.79 |
chr10_117106272_117106596 | 6.11 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24412 |
0.12 |
chr9_63757305_63758776 | 6.06 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr2_153492229_153493481 | 6.02 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr4_136187267_136187442 | 6.01 |
E2f2 |
E2F transcription factor 2 |
6571 |
0.15 |
chr5_139460448_139460733 | 5.99 |
3110082I17Rik |
RIKEN cDNA 3110082I17 gene |
63 |
0.96 |
chr4_141347349_141347551 | 5.98 |
Gm13074 |
predicted gene 13074 |
364 |
0.7 |
chr17_47909349_47909983 | 5.94 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr8_79638728_79640227 | 5.86 |
Otud4 |
OTU domain containing 4 |
141 |
0.96 |
chr8_122550655_122551216 | 5.78 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
394 |
0.72 |
chr4_140684640_140684816 | 5.73 |
Gm13025 |
predicted gene 13025 |
4975 |
0.13 |
chr12_84176344_84176796 | 5.73 |
Gm19327 |
predicted gene, 19327 |
11236 |
0.1 |
chrX_11664322_11665096 | 5.72 |
Gm14513 |
predicted gene 14513 |
19415 |
0.24 |
chr9_72699805_72699974 | 5.71 |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4 |
6450 |
0.11 |
chr2_32128159_32128364 | 5.67 |
Prrc2b |
proline-rich coiled-coil 2B |
22821 |
0.1 |
chr3_145987459_145988897 | 5.66 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
41 |
0.98 |
chr1_86441569_86443004 | 5.62 |
Tex44 |
testis expressed 44 |
15957 |
0.11 |
chr10_121569006_121569830 | 5.61 |
Tbk1 |
TANK-binding kinase 1 |
937 |
0.48 |
chr8_117297499_117297786 | 5.61 |
Cmip |
c-Maf inducing protein |
40525 |
0.17 |
chr10_93731269_93731731 | 5.61 |
Gm15963 |
predicted gene 15963 |
3293 |
0.2 |
chr10_107930414_107930770 | 5.60 |
Gm29685 |
predicted gene, 29685 |
16053 |
0.22 |
chr5_140606846_140607467 | 5.60 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
164 |
0.83 |
chr2_120446459_120446628 | 5.60 |
Ganc |
glucosidase, alpha; neutral C |
6036 |
0.15 |
chr4_118079198_118079529 | 5.59 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
47481 |
0.11 |
chr3_60472720_60472916 | 5.59 |
Mbnl1 |
muscleblind like splicing factor 1 |
12 |
0.99 |
chr11_120114654_120115286 | 5.59 |
Slc38a10 |
solute carrier family 38, member 10 |
4512 |
0.11 |
chr6_99520900_99522395 | 5.53 |
Foxp1 |
forkhead box P1 |
485 |
0.83 |
chr4_132077386_132077728 | 5.52 |
Epb41 |
erythrocyte membrane protein band 4.1 |
2236 |
0.17 |
chr17_45563718_45564975 | 5.51 |
Slc35b2 |
solute carrier family 35, member B2 |
141 |
0.91 |
chr9_46103264_46103463 | 5.48 |
Sik3 |
SIK family kinase 3 |
19767 |
0.17 |
chr11_3289074_3290615 | 5.48 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr10_117106670_117106977 | 5.46 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24023 |
0.12 |
chr17_70850487_70852089 | 5.45 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr9_21615608_21616677 | 5.44 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr5_140209095_140209299 | 5.43 |
Gm16120 |
predicted gene 16120 |
345 |
0.87 |
chr9_114449153_114449315 | 5.39 |
Ccr4 |
chemokine (C-C motif) receptor 4 |
46804 |
0.09 |
chr19_55253850_55254459 | 5.38 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
785 |
0.62 |
chr12_104999283_104999468 | 5.38 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
698 |
0.55 |
chr3_58415944_58417384 | 5.34 |
Tsc22d2 |
TSC22 domain family, member 2 |
786 |
0.64 |
chr14_21074009_21074288 | 5.33 |
Adk |
adenosine kinase |
2004 |
0.35 |
chr13_101612375_101612655 | 5.32 |
Gm29341 |
predicted gene 29341 |
6282 |
0.22 |
chr2_173019275_173020205 | 5.28 |
Rbm38 |
RNA binding motif protein 38 |
758 |
0.54 |
chr11_59518345_59518496 | 5.26 |
Zkscan17 |
zinc finger with KRAB and SCAN domains 17 |
8211 |
0.1 |
chr5_124052020_124052183 | 5.25 |
Gm43661 |
predicted gene 43661 |
251 |
0.85 |
chr6_83456116_83457458 | 5.24 |
Tet3 |
tet methylcytosine dioxygenase 3 |
395 |
0.77 |
chr2_26139656_26141133 | 5.23 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr1_40175246_40175397 | 5.23 |
Il1r1 |
interleukin 1 receptor, type I |
49759 |
0.12 |
chr6_120665862_120666733 | 5.23 |
Cecr2 |
CECR2, histone acetyl-lysine reader |
72 |
0.98 |
chr13_35740610_35741587 | 5.22 |
Cdyl |
chromodomain protein, Y chromosome-like |
215 |
0.94 |
chr18_34410163_34410637 | 5.21 |
Pkd2l2 |
polycystic kidney disease 2-like 2 |
974 |
0.53 |
chr7_127253701_127254925 | 5.16 |
Dctpp1 |
dCTP pyrophosphatase 1 |
6396 |
0.07 |
chr9_106891325_106892191 | 5.14 |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
112 |
0.63 |
chr14_61125304_61125455 | 5.13 |
Sacs |
sacsin |
13078 |
0.21 |
chr7_126271797_126273090 | 5.11 |
Sbk1 |
SH3-binding kinase 1 |
176 |
0.92 |
chr3_51230204_51230396 | 5.10 |
Gm38357 |
predicted gene, 38357 |
1617 |
0.3 |
chr3_96409919_96410258 | 5.10 |
Pafah1b1-ps1 |
platelet-activating factor acetylhydrolase, isoform 1b, beta1 subunit, pseudogene 1 |
1029 |
0.22 |
chr10_62326873_62327250 | 5.07 |
Hk1 |
hexokinase 1 |
706 |
0.65 |
chr3_14878644_14878831 | 5.06 |
Car2 |
carbonic anhydrase 2 |
7536 |
0.19 |
chr12_69758521_69758986 | 5.03 |
Mir681 |
microRNA 681 |
5191 |
0.14 |
chr8_109579830_109579981 | 5.02 |
Hp |
haptoglobin |
733 |
0.57 |
chr11_96943726_96944317 | 5.02 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
35 |
0.62 |
chr2_72908469_72908814 | 4.97 |
Sp3 |
trans-acting transcription factor 3 |
32443 |
0.14 |
chr1_21132344_21132637 | 4.97 |
Gm2693 |
predicted gene 2693 |
46498 |
0.1 |
chr11_19924323_19926342 | 4.95 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr5_139791654_139791955 | 4.92 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
270 |
0.86 |
chr1_178330123_178330310 | 4.87 |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
104 |
0.94 |
chr17_24208511_24209934 | 4.87 |
Ntn3 |
netrin 3 |
177 |
0.67 |
chr5_139382833_139383061 | 4.83 |
Gpr146 |
G protein-coupled receptor 146 |
2366 |
0.18 |
chr2_156840246_156841082 | 4.82 |
Tgif2 |
TGFB-induced factor homeobox 2 |
358 |
0.63 |
chr8_120486990_120488549 | 4.80 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr1_185472414_185472709 | 4.78 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
14733 |
0.12 |
chr5_148379511_148379873 | 4.77 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
8146 |
0.24 |
chr6_115755565_115755728 | 4.75 |
Tmem40 |
transmembrane protein 40 |
3353 |
0.13 |
chr9_21164878_21165667 | 4.75 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
442 |
0.69 |
chr12_30922517_30922677 | 4.74 |
Sh3yl1 |
Sh3 domain YSC-like 1 |
10410 |
0.17 |
chr14_27349855_27350152 | 4.72 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
11386 |
0.2 |
chr4_97777645_97778418 | 4.72 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
17 |
0.72 |
chr10_43479277_43480054 | 4.71 |
Bend3 |
BEN domain containing 3 |
525 |
0.71 |
chr10_94048249_94048471 | 4.68 |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
12359 |
0.12 |
chr11_3337332_3338194 | 4.67 |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
3382 |
0.14 |
chr10_105418346_105418657 | 4.67 |
Gm48203 |
predicted gene, 48203 |
24215 |
0.16 |
chr19_47178446_47179494 | 4.66 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
52 |
0.95 |
chr18_37935413_37935776 | 4.66 |
Diaph1 |
diaphanous related formin 1 |
118 |
0.92 |
chr6_55324727_55325118 | 4.65 |
Aqp1 |
aquaporin 1 |
11510 |
0.14 |
chr1_91533608_91533778 | 4.65 |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
6851 |
0.15 |
chr7_134241262_134241558 | 4.64 |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
9264 |
0.2 |
chr2_71420780_71421359 | 4.63 |
Hat1 |
histone aminotransferase 1 |
977 |
0.47 |
chr6_120579566_120580923 | 4.63 |
Gm44124 |
predicted gene, 44124 |
68 |
0.96 |
chr4_131920531_131921931 | 4.60 |
Tmem200b |
transmembrane protein 200B |
31 |
0.78 |
chr8_111939847_111940172 | 4.58 |
Gabarapl2 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2 |
694 |
0.59 |
chr5_64505055_64505600 | 4.58 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
28292 |
0.11 |
chr13_109682772_109683058 | 4.57 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
3241 |
0.4 |
chr1_134419824_134420010 | 4.57 |
Adipor1 |
adiponectin receptor 1 |
4353 |
0.12 |
chr3_88509686_88510447 | 4.56 |
Lmna |
lamin A |
110 |
0.91 |
chr13_98890078_98890869 | 4.54 |
Tnpo1 |
transportin 1 |
525 |
0.72 |
chr4_139335538_139335703 | 4.54 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1560 |
0.18 |
chr4_151730005_151730352 | 4.51 |
Camta1 |
calmodulin binding transcription activator 1 |
131472 |
0.05 |
chr1_172501740_172502411 | 4.51 |
Tagln2 |
transgelin 2 |
823 |
0.43 |
chr15_83366933_83367626 | 4.51 |
1700001L05Rik |
RIKEN cDNA 1700001L05 gene |
2 |
0.97 |
chr5_50128978_50129261 | 4.49 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
22214 |
0.2 |
chr8_68275265_68275750 | 4.48 |
Sh2d4a |
SH2 domain containing 4A |
1060 |
0.53 |
chr1_86525613_86527056 | 4.47 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr6_146630109_146630279 | 4.47 |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
4304 |
0.15 |
chr11_96956109_96956306 | 4.47 |
D030028A08Rik |
RIKEN cDNA D030028A08 gene |
11895 |
0.08 |
chr1_131084350_131084780 | 4.43 |
Gm37084 |
predicted gene, 37084 |
7584 |
0.14 |
chr9_58657759_58658148 | 4.42 |
Rec114 |
REC114 meiotic recombination protein |
1339 |
0.42 |
chr11_87126714_87127907 | 4.41 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr13_94513441_94513654 | 4.41 |
Gm25109 |
predicted gene, 25109 |
3615 |
0.25 |
chr17_73034947_73035138 | 4.41 |
Gm30420 |
predicted gene, 30420 |
5964 |
0.24 |
chr7_19004190_19004941 | 4.37 |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
521 |
0.54 |
chr19_42128418_42129450 | 4.37 |
Avpi1 |
arginine vasopressin-induced 1 |
55 |
0.96 |
chr4_152039462_152039925 | 4.36 |
Nol9 |
nucleolar protein 9 |
330 |
0.73 |
chr5_122774888_122775039 | 4.36 |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
4318 |
0.15 |
chr11_97440036_97440725 | 4.35 |
Arhgap23 |
Rho GTPase activating protein 23 |
4095 |
0.19 |
chr7_75611639_75612062 | 4.34 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr9_8003315_8004975 | 4.34 |
Yap1 |
yes-associated protein 1 |
245 |
0.79 |
chr16_38289149_38289300 | 4.33 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
5600 |
0.16 |
chr9_64793074_64793409 | 4.33 |
Dennd4a |
DENN/MADD domain containing 4A |
18099 |
0.18 |
chr3_135843797_135843956 | 4.31 |
4933401H06Rik |
RIKEN cDNA 4933401H06 gene |
3607 |
0.18 |
chr17_40794012_40794209 | 4.27 |
Crisp2 |
cysteine-rich secretory protein 2 |
5 |
0.97 |
chr4_152009281_152009999 | 4.27 |
Gm9768 |
predicted gene 9768 |
21 |
0.93 |
chr2_153161013_153161878 | 4.26 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr10_17653857_17654030 | 4.26 |
Gm47771 |
predicted gene, 47771 |
4570 |
0.27 |
chr1_85241821_85242226 | 4.25 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
4374 |
0.13 |
chr1_85454196_85454612 | 4.24 |
AC147806.1 |
novel protein |
30738 |
0.12 |
chr2_154569188_154570416 | 4.24 |
E2f1 |
E2F transcription factor 1 |
82 |
0.95 |
chr2_118658372_118658729 | 4.23 |
Pak6 |
p21 (RAC1) activated kinase 6 |
4753 |
0.16 |
chr5_36713069_36713508 | 4.23 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
17264 |
0.12 |
chr19_40553399_40553745 | 4.23 |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
1169 |
0.39 |
chr11_79992495_79993374 | 4.23 |
Suz12 |
SUZ12 polycomb repressive complex 2 subunit |
172 |
0.95 |
chr15_95855562_95855724 | 4.22 |
Gm25070 |
predicted gene, 25070 |
24174 |
0.13 |
chr7_141340446_141340765 | 4.20 |
Eps8l2 |
EPS8-like 2 |
1599 |
0.18 |
chr4_46452009_46452739 | 4.19 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
1472 |
0.31 |
chr11_97437759_97438365 | 4.18 |
Arhgap23 |
Rho GTPase activating protein 23 |
1777 |
0.31 |
chr10_128525093_128526268 | 4.18 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr6_125095392_125097556 | 4.17 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr4_124997589_124997740 | 4.17 |
Rspo1 |
R-spondin 1 |
9816 |
0.11 |
chr15_77236047_77236198 | 4.17 |
Gm24056 |
predicted gene, 24056 |
6429 |
0.17 |
chr14_69502507_69503231 | 4.16 |
Gm27175 |
predicted gene 27175 |
13 |
0.7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.2 | GO:0036166 | phenotypic switching(GO:0036166) |
4.0 | 12.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
3.9 | 15.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
3.6 | 10.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
3.3 | 6.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
3.1 | 9.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.6 | 13.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.6 | 7.8 | GO:0040031 | snRNA modification(GO:0040031) |
2.3 | 6.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.1 | 8.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
2.1 | 6.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.1 | 6.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
2.1 | 8.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
2.1 | 6.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.9 | 5.8 | GO:0042938 | dipeptide transport(GO:0042938) |
1.9 | 5.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.9 | 1.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.8 | 5.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.8 | 5.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.7 | 5.2 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.7 | 6.8 | GO:0010288 | response to lead ion(GO:0010288) |
1.6 | 4.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 | 4.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.6 | 6.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.5 | 6.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.5 | 4.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.5 | 4.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.5 | 7.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.5 | 4.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.4 | 7.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.4 | 5.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.4 | 1.4 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.4 | 5.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.4 | 9.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.4 | 5.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.3 | 4.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.3 | 5.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.3 | 9.2 | GO:0001842 | neural fold formation(GO:0001842) |
1.3 | 3.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.3 | 5.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.3 | 2.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.3 | 2.5 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.3 | 2.5 | GO:0009176 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.2 | 3.7 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.2 | 6.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.2 | 3.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.2 | 3.7 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.2 | 7.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.2 | 3.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.2 | 3.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.1 | 3.4 | GO:0042117 | monocyte activation(GO:0042117) |
1.1 | 3.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.1 | 2.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.1 | 5.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.1 | 8.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.1 | 5.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.1 | 4.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.1 | 3.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.1 | 3.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 3.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.1 | 3.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.1 | 5.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.0 | 3.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.0 | 2.1 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.0 | 10.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.0 | 3.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 4.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 4.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.0 | 2.0 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.0 | 3.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.0 | 5.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.0 | 7.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 1.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.0 | 2.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 3.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.0 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 1.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.0 | 1.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.0 | 4.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 0.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.9 | 9.5 | GO:0000050 | urea cycle(GO:0000050) |
0.9 | 3.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 3.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 5.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.9 | 1.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.9 | 2.7 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.9 | 17.9 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.9 | 5.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 4.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.9 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 7.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.9 | 9.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.9 | 2.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.9 | 1.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.9 | 0.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 3.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.9 | 13.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.9 | 3.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 4.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 0.9 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.9 | 0.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.8 | 2.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.8 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.8 | 3.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.8 | 0.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 4.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.8 | 4.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.8 | 2.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.8 | 4.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.8 | 2.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.8 | 2.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.8 | 2.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 0.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 4.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 2.4 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 1.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 3.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.8 | 2.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.8 | 3.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 2.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.8 | 2.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 2.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 4.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.8 | 1.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.8 | 3.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.8 | 1.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.8 | 3.8 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.8 | 3.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 2.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.7 | 0.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.7 | 1.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.7 | 2.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 0.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 2.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 2.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 0.7 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.7 | 1.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.7 | 2.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 5.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.7 | 0.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.7 | 3.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 2.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 3.6 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 3.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.7 | 0.7 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.7 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 1.4 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 0.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.7 | 4.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 3.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 2.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 5.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.7 | 1.4 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.7 | 1.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.7 | 2.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.7 | 2.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.7 | 0.7 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.7 | 6.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.7 | 2.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.7 | 3.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 5.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 1.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.7 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 1.3 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 1.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.7 | 3.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 3.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.7 | 0.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.7 | 3.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.7 | 0.7 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.6 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.6 | 3.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 1.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 1.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 2.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 3.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 1.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.6 | 5.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.6 | 1.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 0.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.6 | 3.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 1.8 | GO:0070295 | renal water absorption(GO:0070295) |
0.6 | 1.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.6 | 8.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 1.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.6 | 0.6 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.6 | 4.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.6 | 2.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.6 | 2.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.6 | 4.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.6 | 1.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.6 | 2.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 4.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 4.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.6 | 8.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 4.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 1.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.6 | 2.3 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.6 | 3.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 1.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.6 | 2.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.6 | 8.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.6 | 5.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.6 | 5.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.6 | 5.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.6 | 1.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 13.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.6 | 1.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.6 | 2.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 1.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.6 | 4.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 5.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 1.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.6 | 5.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.6 | 2.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.6 | 1.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 3.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.7 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.6 | 1.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.6 | 2.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.6 | 4.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.6 | 2.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 0.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.6 | 1.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 2.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 1.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 1.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 2.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 0.5 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.5 | 1.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 2.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 1.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 2.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 0.5 | GO:0043217 | myelin maintenance(GO:0043217) |
0.5 | 1.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 3.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 7.4 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 2.7 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.5 | 1.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 1.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 4.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.5 | 1.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 2.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 1.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 2.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 2.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 3.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.5 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 2.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 11.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 1.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 2.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 2.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 7.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.5 | 2.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 2.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 2.0 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.5 | 0.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 7.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 3.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.5 | 1.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.5 | 1.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.5 | 1.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 3.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 5.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.5 | 3.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.5 | 1.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.5 | 1.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 1.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 0.5 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.5 | 1.0 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 4.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 2.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 0.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.5 | 1.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 1.9 | GO:0046137 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.5 | 3.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 1.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 3.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 1.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.5 | 1.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 1.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 2.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 0.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.5 | 2.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.5 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.4 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 3.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 0.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.5 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 2.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.5 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 2.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 1.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 2.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 2.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 1.3 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.4 | 1.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 0.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 0.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 1.8 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.4 | 2.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 8.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 2.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 0.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 2.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 0.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.4 | 1.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 2.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.9 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 1.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 5.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 0.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 2.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 0.4 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.4 | 1.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 2.6 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.4 | 0.4 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 1.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 1.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 1.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 2.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 3.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 2.9 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.4 | 1.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 2.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 4.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 5.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.4 | 0.8 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 7.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 3.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 2.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 3.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 2.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.4 | 3.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.4 | 1.2 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.4 | 1.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 1.6 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 0.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.4 | 10.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.4 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 0.8 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.4 | 1.9 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.4 | 1.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 7.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 2.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 1.5 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 0.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.4 | 0.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 | 1.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 1.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 2.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.4 | 1.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.4 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 2.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 0.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 3.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 1.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.4 | 1.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 4.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 0.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.4 | 2.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 1.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 7.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 0.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.4 | 0.4 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.4 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 1.1 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 2.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 1.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 0.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.4 | 1.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 1.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.4 | 2.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 3.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 1.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.4 | 0.7 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 0.7 | GO:2000670 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 0.7 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.4 | 2.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 1.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 5.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.4 | 0.7 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.4 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 0.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 0.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.4 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 1.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 2.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 1.0 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 1.7 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.3 | 1.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.3 | 5.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 0.7 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 2.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 2.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 2.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 0.7 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.3 | 4.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 3.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.3 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.3 | 1.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 2.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 1.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.3 | 1.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.7 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 0.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 6.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.6 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.3 | 1.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 2.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 0.6 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.3 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 0.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 1.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 1.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 1.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.3 | 2.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.9 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 1.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.3 | GO:0060214 | endocardium formation(GO:0060214) |
0.3 | 0.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 0.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 0.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 3.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 0.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 0.3 | GO:0070254 | mucus secretion(GO:0070254) |
0.3 | 2.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 5.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 2.1 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.3 | 6.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 0.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 4.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 4.4 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
0.3 | 1.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 7.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 2.4 | GO:0070542 | response to fatty acid(GO:0070542) |
0.3 | 0.6 | GO:0072537 | fibroblast activation(GO:0072537) |
0.3 | 1.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 0.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 0.6 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 2.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 2.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 0.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 4.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 4.9 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 1.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.6 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 0.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 2.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.1 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.3 | 5.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.6 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 3.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 1.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 1.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 6.6 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.3 | 1.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.3 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.8 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 2.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.3 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 2.4 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 0.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 2.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 4.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.8 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 1.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.5 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.3 | 0.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 1.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.3 | 0.8 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.3 | 2.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.3 | 0.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 1.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 2.1 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 0.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 1.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 3.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 1.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.3 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 5.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 0.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 5.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.8 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.3 | 0.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 1.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 1.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 0.5 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.2 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 2.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 2.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 3.9 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 1.7 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.2 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 2.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.5 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 1.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.2 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.9 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 2.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.7 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 3.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 1.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 1.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 0.6 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 1.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.2 | 5.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 1.9 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 5.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.4 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.2 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 1.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.2 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.4 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 2.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.2 | 0.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.8 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 1.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.6 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 3.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.8 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 2.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.6 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 2.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 3.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.0 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.6 | GO:0071305 | vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
0.2 | 2.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.2 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.8 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 2.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.2 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 3.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.8 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 4.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.4 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.2 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 1.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.2 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) Schwann cell proliferation(GO:0014010) |
0.2 | 0.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 2.0 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 3.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 1.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.5 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 0.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 2.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.9 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.9 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.9 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.2 | GO:0006241 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.2 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 1.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.7 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 0.7 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.2 | 1.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.7 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.8 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 0.3 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 2.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.3 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.8 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 1.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.2 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 1.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 1.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.2 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.8 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 1.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 2.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.2 | 0.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 0.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 0.5 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 1.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 3.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 1.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 1.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 5.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.4 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 3.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 2.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 2.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.7 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.1 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.3 | GO:0052803 | histamine metabolic process(GO:0001692) imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 3.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.3 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 1.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 2.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 1.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 1.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.6 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 1.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 2.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.5 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.6 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 1.1 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 2.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.1 | 0.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.1 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 2.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 1.1 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 1.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 1.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 2.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0009118 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 1.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 1.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 1.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.7 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 1.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.9 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.5 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 1.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 1.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 1.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.3 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 0.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.1 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 1.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.2 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.1 | 1.1 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 1.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.5 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 1.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.1 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.1 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.1 | 0.7 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 3.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.4 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 1.4 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.6 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.3 | GO:1900426 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.3 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 1.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.3 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.6 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.2 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 1.1 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.1 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.1 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.5 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 4.5 | GO:0030217 | T cell differentiation(GO:0030217) |
0.1 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.5 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 1.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 2.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 2.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 2.3 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.1 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.5 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 1.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.6 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 1.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 1.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.6 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 1.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 1.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.9 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.8 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 1.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.1 | 0.3 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.0 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.5 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.0 | 0.3 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.0 | 1.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.5 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 1.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 1.1 | GO:0015758 | glucose transport(GO:0015758) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.3 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 1.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.2 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.6 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:0019076 | viral release from host cell(GO:0019076) |
0.0 | 0.0 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.2 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 1.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 1.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.0 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.0 | 0.1 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.0 | GO:0097306 | cellular response to alcohol(GO:0097306) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:2000667 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0002827 | regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.0 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.0 | 0.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 1.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.0 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 9.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.2 | 8.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.2 | 6.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.1 | 4.1 | GO:0001739 | sex chromatin(GO:0001739) |
2.0 | 6.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.7 | 9.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 6.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.3 | 5.3 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 4.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.2 | 5.8 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 3.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.1 | 5.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 12.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 5.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.0 | 9.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.9 | 2.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 9.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 3.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 2.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 2.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.9 | 3.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 4.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 2.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 2.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 7.8 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 3.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 2.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 4.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 4.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 6.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.7 | 4.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.7 | 3.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 2.6 | GO:0035363 | histone locus body(GO:0035363) |
0.7 | 2.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 1.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.6 | 19.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 5.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 9.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 3.6 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.6 | 17.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 2.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 3.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 1.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 2.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 1.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 4.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.5 | 3.1 | GO:0000243 | commitment complex(GO:0000243) |
0.5 | 2.0 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 6.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 2.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 3.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 23.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 4.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 4.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 2.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 1.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 5.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 2.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 4.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 1.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 0.5 | GO:0030135 | coated vesicle(GO:0030135) |
0.5 | 3.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 3.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 3.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 4.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 2.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 7.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 5.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 2.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 3.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 1.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 1.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 8.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 20.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 3.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 3.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 7.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.4 | 1.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 12.7 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 2.7 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 4.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 0.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 3.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 3.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 1.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 5.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 2.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 2.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.4 | 6.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 10.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 21.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 2.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 7.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 3.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 4.1 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 5.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 5.6 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 48.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 2.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 3.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 2.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 2.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 3.3 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 1.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 2.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 2.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 11.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.8 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 3.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 3.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 4.6 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 10.2 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 1.7 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 1.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 3.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 6.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 1.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 2.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 6.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 2.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 3.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 3.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.2 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 13.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 2.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 1.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 1.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 5.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 2.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 8.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 0.2 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) USH2 complex(GO:1990696) |
0.2 | 0.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 3.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 5.1 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 1.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 8.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 1.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.2 | GO:1990462 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 3.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 6.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 41.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.6 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 1.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.4 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 3.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 6.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 3.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 4.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 3.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 2.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 7.1 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 2.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 3.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 2.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 7.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.6 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 4.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 15.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 7.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 3.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 32.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 3.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 3.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 6.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 4.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 136.6 | GO:0031981 | nuclear lumen(GO:0031981) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.4 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 2.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 3.7 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 3.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 1.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 3.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 1.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 3.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.7 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 13.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 3.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.0 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 3.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 28.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.6 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 61.8 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
3.5 | 10.6 | GO:0030519 | snoRNP binding(GO:0030519) |
3.0 | 3.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.3 | 9.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.3 | 6.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.0 | 6.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.0 | 11.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.9 | 7.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
1.8 | 5.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.8 | 5.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.8 | 7.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.6 | 4.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.6 | 14.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.6 | 6.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.6 | 10.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.4 | 5.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.4 | 9.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 4.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 4.0 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.3 | 6.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.3 | 2.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.3 | 3.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.2 | 1.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
1.2 | 7.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.2 | 3.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.2 | 6.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.2 | 4.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 9.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.1 | 3.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.1 | 4.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.0 | 4.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 3.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.0 | 13.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.0 | 4.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.0 | 5.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.0 | 4.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 4.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 21.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.9 | 2.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 3.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 3.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.9 | 2.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 10.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.9 | 2.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.9 | 2.6 | GO:0070905 | serine binding(GO:0070905) |
0.9 | 3.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.9 | 5.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 3.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 2.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 2.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 3.3 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 2.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 2.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 9.9 | GO:0015250 | water channel activity(GO:0015250) |
0.8 | 3.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 10.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.8 | 6.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 3.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 4.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 2.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.8 | 2.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 3.7 | GO:0070061 | fructose binding(GO:0070061) |
0.7 | 2.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.7 | 2.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 3.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.7 | 2.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.7 | 2.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 12.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 2.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.7 | 2.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 2.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.7 | 2.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 2.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.7 | 2.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 3.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 8.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.7 | 13.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 1.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 5.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 2.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.7 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 3.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 1.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 2.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 1.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.6 | 3.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 5.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.6 | 2.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 10.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.6 | 11.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 2.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 11.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 5.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.9 | GO:0043888 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.6 | 3.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 4.3 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 1.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 2.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 1.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 1.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 7.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 1.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.6 | 2.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.6 | 2.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 2.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 3.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 1.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.6 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 2.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 2.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 17.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 4.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 3.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 4.5 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.6 | 3.9 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 4.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 2.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 21.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 2.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 3.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 1.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 3.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 2.1 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.5 | 6.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 2.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 2.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 4.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 1.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 1.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 3.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 6.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 3.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.5 | 3.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 1.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 2.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 1.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.5 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 5.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 1.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 1.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.5 | 1.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 3.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 14.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.5 | 1.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 1.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 2.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 0.9 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 3.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 2.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 1.2 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 1.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 2.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 3.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 2.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 4.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 2.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 1.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 3.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 2.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 2.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 1.2 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.4 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 2.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 7.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.4 | 1.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 2.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 2.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 1.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 4.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.5 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 2.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 5.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 1.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 7.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 4.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 1.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 1.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 3.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 0.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 6.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 6.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 2.9 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 2.8 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 2.7 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 2.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 3.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.3 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 2.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 1.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 2.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 4.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 11.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 0.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 2.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 3.8 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.3 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.3 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 4.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 4.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 3.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 2.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 1.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.7 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 0.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 0.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 2.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 2.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.3 | 3.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 0.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 1.4 | GO:0034802 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 1.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 3.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 2.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 2.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 6.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 2.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 4.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 4.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.3 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 4.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 2.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 2.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 2.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 2.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 52.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 2.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 3.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 2.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 6.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 7.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 6.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 2.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 2.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.4 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 0.9 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 2.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.2 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 3.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 5.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.6 | GO:0051731 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 2.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 2.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 4.3 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 1.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 5.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.6 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.2 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 7.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.6 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.1 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 10.7 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 6.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 6.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 3.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 13.3 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 2.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 1.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 3.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 4.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 16.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 8.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 13.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 2.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 1.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 3.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 3.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 8.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 4.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 7.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 3.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 2.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 4.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 3.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.7 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 9.5 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 6.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.7 | GO:0016841 | carbon-nitrogen lyase activity(GO:0016840) ammonia-lyase activity(GO:0016841) |
0.1 | 1.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 3.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.4 | GO:0034956 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 3.4 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 1.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 2.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 1.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 2.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.9 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 2.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 5.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 5.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 2.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 5.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.7 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 6.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 1.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.5 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 3.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.3 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 6.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 2.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 2.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.3 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 5.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 2.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 2.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 1.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 9.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 9.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 3.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 1.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 8.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 10.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 1.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 5.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.8 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 2.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 6.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 11.6 | ST STAT3 PATHWAY | STAT3 Pathway |
1.1 | 15.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.0 | 6.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.9 | 9.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.9 | 2.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.9 | 10.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 16.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 12.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 6.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.7 | 18.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 33.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 4.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 28.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 3.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 7.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.6 | 26.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 13.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 8.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 4.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 27.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 4.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 6.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 5.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 3.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 7.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 16.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 3.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 4.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 9.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 8.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 8.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 9.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 3.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 10.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 4.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 10.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 5.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 2.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 6.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 2.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 5.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 11.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 7.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 3.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 6.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 10.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 7.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 6.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 3.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 1.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 9.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 9.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 3.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 7.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 2.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 4.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 6.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 4.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 5.0 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 4.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 6.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 2.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 3.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.5 | 13.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.4 | 5.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.3 | 24.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.1 | 17.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 7.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.9 | 8.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 10.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 7.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.8 | 25.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 8.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 8.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 8.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 5.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 14.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 1.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 7.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 18.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 11.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.6 | 2.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 9.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.6 | 7.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 5.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 2.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.6 | 23.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 1.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.6 | 5.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 6.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 6.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 5.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 4.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 6.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 10.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 1.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 8.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 2.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 7.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 5.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 7.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 3.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 3.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 6.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.4 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 5.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.4 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.4 | 4.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 5.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 13.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 10.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 4.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 3.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 2.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 6.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 7.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 5.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 5.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 3.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 2.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 0.3 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 20.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 4.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 6.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 8.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 6.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 4.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 4.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 4.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 4.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 3.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 3.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 0.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 2.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 18.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 2.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 2.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 2.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 20.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 3.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 1.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 4.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 0.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.2 | 1.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 3.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 4.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 5.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 2.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 7.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 0.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 4.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 1.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 5.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 3.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 2.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.7 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 4.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 7.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.5 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 2.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.7 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 2.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 4.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.5 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
0.1 | 12.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 12.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 6.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 1.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME SIGNALING BY INSULIN RECEPTOR | Genes involved in Signaling by Insulin receptor |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 1.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |